Stan Berenshteyn
Stock Analyst at Wells Fargo
(0.17)
# 4,274
Out of 4,408 analysts
278
Total ratings
42.6%
Success rate
-9.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Maintained: Buy | $80 | $68.35 | +17.04% | 4 | Jun 12, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $320 | $162.17 | +97.32% | 39 | Jun 10, 2026 | |
| DOCS Doximity | Maintained: Hold | $18 | $20.68 | -12.96% | 32 | Jun 10, 2026 | |
| HQY HealthEquity | Rated: Buy | $125 | $86.97 | +43.73% | 55 | Jun 5, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $3.5 | $2.73 | +28.21% | 35 | Jun 2, 2026 | |
| PHR Phreesia | Reiterated: Hold | $9 | $9.15 | -1.64% | 6 | May 28, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $1 | $1.84 | -45.65% | 24 | May 11, 2026 | |
| OMDA Omada Health | Maintained: Hold | $17 → $18 | $17.33 | +3.87% | 4 | May 8, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $6 | $7.46 | -19.57% | 8 | Apr 30, 2026 | |
| OMCL Omnicell | Reiterated: Buy | $55 | $39.99 | +37.53% | 53 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $30 → $22 | $30.61 | -28.13% | 3 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 → $36 | $18.55 | +94.07% | 2 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $12 | $8.69 | +38.09% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $14.23 | n/a | 1 | Oct 6, 2015 |
Hinge Health
Jun 12, 2026
Maintained: Buy
Price Target: $80
Current: $68.35
Upside: +17.04%
Veeva Systems
Jun 10, 2026
Maintained: Buy
Price Target: $320
Current: $162.17
Upside: +97.32%
Doximity
Jun 10, 2026
Maintained: Hold
Price Target: $18
Current: $20.68
Upside: -12.96%
HealthEquity
Jun 5, 2026
Rated: Buy
Price Target: $125
Current: $86.97
Upside: +43.73%
GoodRx Holdings
Jun 2, 2026
Maintained: Buy
Price Target: $3.5
Current: $2.73
Upside: +28.21%
Phreesia
May 28, 2026
Reiterated: Hold
Price Target: $9
Current: $9.15
Upside: -1.64%
Health Catalyst
May 11, 2026
Maintained: Hold
Price Target: $1
Current: $1.84
Upside: -45.65%
Omada Health
May 8, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $17.33
Upside: +3.87%
Teladoc Health
Apr 30, 2026
Maintained: Hold
Price Target: $6
Current: $7.46
Upside: -19.57%
Omnicell
Apr 29, 2026
Reiterated: Buy
Price Target: $55
Current: $39.99
Upside: +37.53%
Mar 19, 2026
Rated: Hold
Price Target: $30 → $22
Current: $30.61
Upside: -28.13%
Feb 19, 2026
Reiterated: Buy
Price Target: $41 → $36
Current: $18.55
Upside: +94.07%
Aug 7, 2025
Maintained: Buy
Price Target: $15 → $12
Current: $8.69
Upside: +38.09%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $14.23
Upside: n/a